The singer Enrique Iglesias has closed a deal to sell his catalog of songs and his image rights in a reported nine-figure deal. So what is it that makes music such an attractive alternative investment?
Elsewhere, a sharp reset in private market valuations has stripped numerous so-called unicorns of their status and Swiss drugmaker Roche has agreed to acquire Carmot, the west-coast-based biotechnology company for up to $3.1bn, fueled by the frenzied demand for obesity medicines.
Join a free M&A Finance Accelerator simulation www.amplifyme.com/mafa
Hosted on Acast. See acast.com/privacy for more information.
